14.10.2018 • News

Celanese to Buy India’s Next Polymers

Celanese to Buy India’s Next Polymers (c) Next Polymers
Celanese to Buy India’s Next Polymers (c) Next Polymers

US specialty materials company Celanese has agreed to acquire India’s Next Polymers, one of the country’s largest engineering thermoplastics (ETP) compounders.

Headquartered in Mumbai, Next Polymers specializes in custom compounding various ETPs, including nylon 6 and 6,6, PP, ABS, PC and polymethyl methacrylate (PMMA), for automotive, electrical/electronic, industrial and consumer applications.

“Next Polymers complements our rapidly growing India business to further establish Celanese as a leader in the Indian ETP market by broadening our ability to serve nylon and other engineered materials customers in a high-growth region,” said Scott Sutton, Celanese’s chief operating officer. “Additionally, this acquisition further supports the company’s global manufacturing base by adding a world-class domestic compounding facility with 10 production lines to support our local customers, leverage a potential export base, and expand our domestic ETP capabilities in a market that is growing at a 15 percent annual growth rate.”

Celanese expects to close the transaction in the first quarter of 2019, pending customary closing conditions. Financial details were not disclosed.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.